Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro.
The metastatic spread of cancer is a complex process that involves the combination of different cellular actions including cell adhesion to the extracellular matrix (ECM), breakdown of the ECM by specific matrix-degrading proteinases, and active cell locomotion. Contortrostatin (CN), a homodimeric snake venom disintegrin, has previously been demonstrated to be effective in blocking vitronectin/fibronectin-dependent adhesion and invasion of T98G human glioblastoma cells through Matrigel using in vitro studies. However, it is not known at what step of the invasion process CN exerts its inhibitory effect. In the present report, CN is shown to decrease invasion of various glioma cell lines through Matrigel affecting neither cell adhesion, nor cell viability. While CN had no effect on cell binding to laminin and type IV collagen, it blocked adhesion of alphav beta3-positive, but not alphav beta3-negative cells, to vitronectin and fibronectin. Furthermore, members of the matrix metalloproteinase (MMP) family and their physiological inhibitors, and of the plasminogen activator (PA)/plasmin system were demonstrated not to be involved in CN-induced loss of glioma cell invasiveness. Instead, CN inhibited active locomotion of cells on Matrigel. These data suggest that CN-mediated inhibition of glioma cell invasion through Matrigel is a direct result of impaired cell motility. Moreover, use of several glioma cell lines and integrin antibodies strongly indicates the versatility of CN in inhibiting the invasion process based on the ability of CN to interact with different integrins, including alphav beta3, alphav beta5, and alpha5beta1.
Schmitmeier
Stephanie
S
Department of Biochemistry and Molecular Biology, University of Southern California, Keck School of Medicine and Norris Comprehensive Cancer Center, 1200 N. State St. #5046, Los Angeles, CA 90033, USA.
Markland
Francis S
FS
Ritter
Matthew R
MR
Sawcer
David E
DE
Chen
Thomas C
TC
D015153:Blotting, Western; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D002465:Cell Movement; D002469:Cell Separation; D002470:Cell Survival; D003094:Collagen / Q000737:chemistry; D024141:Collagen Type IV / Q000737:chemistry; D018450:Disease Progression; D019483:Disintegrins / Q000737:chemistry* / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005353:Fibronectins; D005434:Flow Cytometry; D005910:Glioma / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D066298:In Vitro Techniques; D039302:Integrin alphaVbeta3 / Q000378:metabolism; D007797:Laminin / Q000737:chemistry; D009361:Neoplasm Invasiveness; D011233:Precipitin Tests; D011509:Proteoglycans / Q000737:chemistry; D012910:Snake Venoms / Q000737:chemistry*; D019096:Vitronectin / Q000737:chemistry
D024141:Collagen Type IV; D019483:Disintegrins; D004338:Drug Combinations; D005353:Fibronectins; D039302:Integrin alphaVbeta3; D007797:Laminin; D011509:Proteoglycans; D012910:Snake Venoms; D019096:Vitronectin; C403494:contortrostatin; C059485:matrigel; D003094:Collagen